Early Access — free while we kick the tires
EdgarHawk

Marques Tiago

Chief Executive Officer

Director Officer
1 filing analyzed · 1 company · Latest 2025-12-01

Never miss a filing from Marques Tiago

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Pasithea Therapeutics Corp. KTTA 1 0 Net buying

Activity

December 2025
high
Buy
33,333 shares
$25,000
Significance 7/10

CEO Marques Tiago bought 33,333 shares at $0.75 (Nov 28); cluster buy pattern with 2 other insiders in past 14 days

Marques Tiago, Chief Executive Officer, purchased 33,333 shares at $0.75, increasing his holdings by +83.3% from 40,001 to 73,334 shares. This purchase coincides with a cluster pattern: 2 other insiders also bought within the past 14 days. The company shows strong revenue growth of +3130.4% (annual), yet remains unprofitable with net income of $-3,037,420.00 over its most recent full fiscal year and $-3.0M in the latest quarter. At the transaction price of $0.75, the stock has since recovered to $1.16 (+42.6% over 30 days, +29.1% over 90 days) but remains -63.2% from its 52-week high of $3.15, suggesting the purchase was made during a down period relative to recent peak. The coordinated buying activity by multiple insiders warrants examination of whether material information or strategic developments underpin these acquisitions, particularly given the company's unprofitable status and elevated recent volatility.

Related insiders